Head-to-head · Cost-Efficiency Index
Boston Medical Group vs Potere Health MD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Boston Medical Group
Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.
Visit Boston Medical GroupPotere Health MD
Cost-first shoppers who want low-cost, physician-led GLP-1 weight loss without a subscription.
Visit Potere Health MDThe verdict
Boston Medical Group and Potere Health MD tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with Boston Medical Group (ranked #269, a hair above #276) — Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate. But Potere Health MD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Boston Medical Group.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Boston Medical Group | Potere Health MD |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | $199/mo (starting strength, rising with dose, compounded) | $80/mo (starting dose, compounded) |
| Tirzepatide / mo | Not disclosed | $135/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $960 |
| Tirzepatide / yr (modeled) | — | $1,620 |
| Coverage | 7 states | 1 state |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #269 | #276 |
Boston Medical Group
59/100Where the value is
- An established medical group with a defined 12-week program rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
The tradeoffs
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week program totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
Potere Health MD
59/100Where the value is
- Low starting pricing (about $80-$135/month) with no subscription lock-in
- Physician-led by a named MD, not automated messaging
- Third-party COA and LegitScript-certified pharmacy
The tradeoffs
- Available in Utah only — a St George clinic offering telehealth within the state, not a national service
- The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.